Skip to main content

Current Hematologic Malignancy Reports

Ausgabe 5/2022

Inhalt (6 Artikel)

Germline Predisposition to Myeloid Neoplasms (M. Patnaik, Section Editor)

ANKRD26-Related Thrombocytopenia and Predisposition to Myeloid Neoplasms

Mia J. Sullivan, Elizabeth L. Palmer, Juliana Perez Botero

Germline Predisposition to Myeloid Neoplasms (M Patnaik, Section Editor)

Germline and Somatic Defects in DDX41 and its Impact on Myeloid Neoplasms

Talha Badar, Timothy Chlon

Open Access Chronic Myeloid Leukemias (V Oehler, Section Editor)

Management of Chronic Myeloid Leukemia in Children and Young Adults

Maegan Ford, Michael Mauro, Catherine Aftandilian, Kathleen M. Sakamoto, Nobuko Hijiya

Open Access Myeloproliferative Neoplasms (P Bose, Section Editor)

Towards a Personalized Definition of Prognosis in Philadelphia-Negative Myeloproliferative Neoplasms

Barbara Mora, Francesco Passamonti

Myeloproliferative Neoplasms (P Bose, Section Editor)

Novel Therapies in Myelofibrosis: Beyond JAK Inhibitors

Julian A. Waksal, John Mascarenhas

Myeloproliferative Neoplasms (P Bose, Section Editor)

Advances in Risk Stratification and Treatment of Polycythemia Vera and Essential Thrombocythemia

Ivan Krecak, Marko Lucijanic, Srdan Verstovsek

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.